Topic
Chris Williamson
In this podcast, journalist Johann Hari explores the rise of GLP1 agonists like Ozempic and Mounjaro, weighing their extraordinary benefits against potential risks. He recounts his personal journey after attending a party in winter 2022 where he noticed that everyone had lost significant weight desp …
Chris Williamson
The discussion centers on how GLP-1 drugs like Ozempic rebalance food consumption within a novel, hyperpalatable environment by adding weight to both sides of the scale rather than creating a perfect solution. While some individuals have radically changed their diets or reduced portion sizes signifi …
Andrew Huberman
Dr. Zachary Knight, a Howard Hughes Medical Institute investigator and professor at UCSF, explains that food intake regulation relies on two distinct neural systems operating on different time scales: short-term circuits in the brainstem controlling meal size over minutes to hours, and long-term cir …